Year: 2021

news_6

IASO Biotherapeutics and Innovent Biologics to Present Updated Data from its Anti-BCMA CAR-T Therapy in Relapsed/Refractory Multiple Myeloma at European Hematology Association (EHA) Congress

PLEASANTON, Calif. & NANJING, China--(BUSINESS WIRE)--#AutoimmuneDiseases--IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in the discovery and development of...